BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12599420)

  • 1. [Inhibition of constitutively activated Jak3 and induction of apoptosis in NALM-6 cell line].
    Hu W; Zhang C; Zhang P; Wei D; Zhao Z; Cai M
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):25-7. PubMed ID: 12599420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
    Sudbeck EA; Liu XP; Narla RK; Mahajan S; Ghosh S; Mao C; Uckun FM
    Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
    Miyamoto N; Sugita K; Goi K; Inukai T; Lijima K; Tezuka T; Kojika S; Nakamura M; Kagami K; Nakazawa S
    Leukemia; 2001 Nov; 15(11):1758-68. PubMed ID: 11681418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
    Amin HM; Medeiros LJ; Ma Y; Feretzaki M; Das P; Leventaki V; Rassidakis GZ; O'Connor SL; McDonnell TJ; Lai R
    Oncogene; 2003 Aug; 22(35):5399-407. PubMed ID: 12934099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
    Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
    Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH; Chen XY; Cai KR
    Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.
    Granato M; Chiozzi B; Filardi MR; Lotti LV; Di Renzo L; Faggioni A; Cirone M
    Cancer Lett; 2015 Oct; 366(2):191-7. PubMed ID: 26184999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.
    Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D
    Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia.
    Uckun FM; Pitt J; Qazi S
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):37-48. PubMed ID: 21070101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
    Soleymani Fard S; Jeddi Tehrani M; Ardekani AM
    Prostaglandins Leukot Essent Fatty Acids; 2012 Jul; 87(1):17-24. PubMed ID: 22749740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
    Meydan N; Grunberger T; Dadi H; Shahar M; Arpaia E; Lapidot Z; Leeder JS; Freedman M; Cohen A; Gazit A; Levitzki A; Roifman CM
    Nature; 1996 Feb; 379(6566):645-8. PubMed ID: 8628398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Targeted killing of the Nalm-6 cells with 2E8-Genistein immunotoxin and its mechanism].
    Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):57-61. PubMed ID: 19573385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AG490 inhibits the proliferation of human medullary thyroid carcinoma TT cells and increases their radiosensitivity].
    Li J; Gan S; Luo C; Liu S; Peng Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):753-7. PubMed ID: 26062416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M; Nakao K; Goto T; Nishimura D; Kawashimo H; Shibata H; Motoyoshi Y; Taura N; Ichikawa T; Hamasaki K; Eguchi K
    J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S; Bonavida B
    Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
    Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
    Oshiro MM; Landowski TH; Catlett-Falcone R; Hazlehurst LA; Huang M; Jove R; Dalton WS
    Clin Cancer Res; 2001 Dec; 7(12):4262-71. PubMed ID: 11751528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.
    Jin Y; Cao Q; Chen C; Du X; Jin B; Pan J
    BMC Cancer; 2015 Apr; 15():226. PubMed ID: 25884180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.